Crinetics Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. 

CEO
Scott R. Struthers
CEOScott R. Struthers
Employees
143
Employees143
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
143
Employees143

CRNX Key Statistics

Market cap
973.75M
Market cap973.75M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
255.62K
Average volume255.62K
High today
High today
Low today
Low today
Open price
$17.84
Open price$17.84
Volume
0.00
Volume0.00
52 Week high
$28.95
52 Week high$28.95
52 Week low
$15.91
52 Week low$15.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

CRNX Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 30, Pre-Market
ActualExpected Mar 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.